Synthesis method of cefotiam hexetil process impurity

A kind of cefotiam pivoxil and technology of synthesis method, applied in the field of medicine

Active Publication Date: 2016-09-28
ZHEJIANG YONGNING PHARMA
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] By consulting the literature, it is found that there is no literature report on the cefotiam process impu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of cefotiam hexetil process impurity
  • Synthesis method of cefotiam hexetil process impurity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Add 15.8g (0.1mol) of 2-amino-4-thiazoleacetic acid, 44g (0.25mol) of 2-amino-4-thiazole acetyl chloride, and 268ml of water in sequence in the reaction flask, add 35ml of triethylamine, and put the reaction flask into In a microwave reactor, react at 125°C for 20 minutes, adjust the pH to 3.0 with 1N concentrated hydrochloric acid, precipitate a light yellow solid, filter, and wash the filter residue with water and acetone in sequence to obtain 39.4 g of the light yellow target product, with a yield of 90% and a liquid phase purity of 99.6 %. 1 H-NMR (DMSO-d 6 ):6.98(s,1H),6.95(s,2H),6.73(s,1H),6.31(s,1H),3.92(s,2H),3.54(s,2H),3.32(s,2H) . 13 C-NMR (DMSO-d 6 ):172.7,168.8,168.7,168.6,158.0,157.8,148.4,145.3,145.1,110.5,106.2,103.4,41.7,38.6,38.3.LC-MS[M+H] + :439.0.

[0022] HPLC detection conditions are as follows:

[0023] Column: CAPCELL PAK ACR-C18 liquid chromatography column, inner diameter 4.6mm, length 25cm, particle diameter 5μm. Column temperature: 35°...

Embodiment 2

[0025] Add 15.8g (0.1mol) of 2-amino-4-thiazoleacetic acid, 44g (0.25mol) of 2-amino-4-thiazole acetyl chloride, and 268ml of water in sequence in the reaction flask, add 35ml of triethylamine, and put the reaction flask into In an oil bath, react at 125°C for 20 minutes, adjust the pH to 3.0 with 1N concentrated hydrochloric acid, precipitate a light yellow solid, filter, and wash the filter residue with water and acetone in sequence to obtain 0.9 g of the light yellow target product, with a yield of 2% and a liquid phase purity of 92.5% .

Embodiment 3

[0027] Add 15.8g (0.1mol) of 2-amino-4-thiazoleacetic acid, 44g (0.25mol) of 2-amino-4-thiazole acetyl chloride, and 268ml of water in sequence in the reaction flask, add 35ml of triethylamine, and put the reaction flask into In an oil bath, react at 125°C for 12 hours, adjust the pH to 3.0 with 1N concentrated hydrochloric acid, precipitate a light yellow solid, filter, and wash the filter residue with water and acetone successively to obtain 8 g of the light yellow target product, with a yield of 22.5% and a liquid phase purity of 92.7%.

[0028] Through the comparison of Example 1, Example 2, and Example 3, it is found that microwave-assisted catalysis significantly improves the reaction rate and yield.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and mainly relates to a preparation method of a cefotiam hexetil process impurity of 2-(2-(2-(2-(2-(2-aminothiazole-4-yl)-acetamido) thiazole-4-yl)-acetamido) thiazole-4-yl) acetic acid. According to the method, 2-amino-4-thiazole acetic acid and 2-amino-4-thiazole acetyl chloride are used as raw materials to be dissolved into a solvent; microwaves are used for assisting the base catalysis reaction; the pH is regulated to an acid state; filtration and washing are performed to obtain the 2-(2-(2-(2-(2-(2-aminothiazole-4-yl)-acetamido) thiazole-4-yl)-acetamido) thiazole-4-yl) acetic acid, i.e., the cefotiam hexetil process impurity. The reaction equation is shown as the accompanying drawing. Therefore the method has the characteristics that the reaction time is short; the synthesis operation is simple and convenient; the purification operation is easy; the yield is high; the purity is high; the product can be used as a necessary product of cefotiam hexetil quality control or can be applied to the cefotiam hexetil impurity reference substance study, and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine, and mainly relates to a process impurity of cefotiam pivoxil: 2-(2-(2-(2-(2-(2-aminothiazol-4-yl)-acetamido)thiazole-4 -yl)-acetamido)thiazol-4-yl)acetic acid preparation method. Background technique [0002] Cefotiam was first developed by Takeda Pharmaceutical Co., Ltd., Japan. This strain is an oral antibiotic produced by esterification of cefotiam ethyl for injection. Its structural formula is: [0003] [0004] This product itself has no antibacterial effect, and is rapidly hydrolyzed into cefotiam (CTM) in the intestinal mucosa after oral administration and absorbed. The antibacterial activity of CTM against Gram-positive and negative bacteria is the same as that of previous oral cephalosporins, and it is stable to β-lactamase. This product is clinically isolated Staphylococcus aureus, coagulase-negative Staphylococcus pneumoniae, Streptococcus pneumoniae, Neisseria gonorrhoeae, Ampi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D277/46
CPCC07D277/46
Inventor 叶天健陈鑫陈识峰蔡翔金彬书
Owner ZHEJIANG YONGNING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap